Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $102,439 - $123,657
-381 Reduced 32.26%
800 $227,000
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $301,981 - $340,671
1,181 New
1,181 $340,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Veritas Investment Partners (Uk) Ltd. Portfolio

Follow Veritas Investment Partners (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritas Investment Partners (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Veritas Investment Partners (Uk) Ltd. with notifications on news.